Kathleen D Liu1, Jingrong Yang2, Thida C Tan2, David V Glidden3, Sijie Zheng4, Leonid Pravoverov4, Chi-Yuan Hsu5, Alan S Go6. 1. Division of Nephrology, Department of Medicine, University of California, San Francisco, CA. Electronic address: kathleen.liu@ucsf.edu. 2. Division of Research, Kaiser Permanente Northern California, Oakland, CA. 3. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA. 4. Department of Nephrology, Kaiser Permanente Oakland Medical Center, Oakland, CA. 5. Division of Nephrology, Department of Medicine, University of California, San Francisco, CA; Division of Research, Kaiser Permanente Northern California, Oakland, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA. 6. Division of Nephrology, Department of Medicine, University of California, San Francisco, CA; Division of Research, Kaiser Permanente Northern California, Oakland, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA; Department of Medicine, Stanford University School of Medicine, Stanford, CA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA.
Abstract
RATIONALE & OBJECTIVE: Acute kidney injury (AKI) has numerous sequelae. Repeated episodes of AKI may be an important determinant of adverse outcomes, including chronic kidney disease and death. In a population-based cohort study, we sought to determine the incidence of and predictors for recurrent AKI. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 38,659 hospitalized members of Kaiser Permanente Northern California who experienced an episode of AKI from 2006 to 2013. PREDICTORS: Demographic, clinical, and laboratory data, including baseline kidney function, proteinuria, hemoglobin level, comorbid conditions, and severity of AKI. OUTCOMES: Incidence and predictors of recurrent AKI. ANALYTICAL APPROACH: Multivariable Cox proportional hazard regression. RESULTS: 11,048 (28.6%) experienced a second hospitalization complicated by AKI during follow-up (11.2 episodes/100 person-years), with the second episode of AKI occurring a median of 0.6 (interquartile range, 0.2-1.9) years after the first hospitalization. In multivariable analyses, older age, black race, and Hispanic ethnicity were associated with recurrent AKI, along with lower estimated glomerular filtration rate, proteinuria, and anemia. Concomitant conditions, including heart failure, acute coronary syndrome, diabetes, and chronic liver disease, were also multivariable predictors of recurrent AKI. Those who had higher acuity of illness during the initial hospitalization were more likely to have recurrent AKI, but greater AKI severity of the index episode was not independently associated with increased risk for recurrent AKI. In multivariable analysis of matched patients, recurrent AKI was associated with an increased rate of death (HR, 1.66; 95% CI, 1.57-1.77). LIMITATIONS: Analyses were based on clinically available data, rather than protocol-driven timed measurements of kidney function. CONCLUSIONS: Recurrent AKI is a common occurrence after a hospitalization complicated by AKI. Based on routinely available patient characteristics, our findings could facilitate identification of the subgroup of patients with AKI who may benefit from more intensive follow-up to potentially avoid recurrent AKI episodes.
RATIONALE & OBJECTIVE:Acute kidney injury (AKI) has numerous sequelae. Repeated episodes of AKI may be an important determinant of adverse outcomes, including chronic kidney disease and death. In a population-based cohort study, we sought to determine the incidence of and predictors for recurrent AKI. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 38,659 hospitalized members of Kaiser Permanente Northern California who experienced an episode of AKI from 2006 to 2013. PREDICTORS: Demographic, clinical, and laboratory data, including baseline kidney function, proteinuria, hemoglobin level, comorbid conditions, and severity of AKI. OUTCOMES: Incidence and predictors of recurrent AKI. ANALYTICAL APPROACH: Multivariable Cox proportional hazard regression. RESULTS: 11,048 (28.6%) experienced a second hospitalization complicated by AKI during follow-up (11.2 episodes/100 person-years), with the second episode of AKI occurring a median of 0.6 (interquartile range, 0.2-1.9) years after the first hospitalization. In multivariable analyses, older age, black race, and Hispanic ethnicity were associated with recurrent AKI, along with lower estimated glomerular filtration rate, proteinuria, and anemia. Concomitant conditions, including heart failure, acute coronary syndrome, diabetes, and chronic liver disease, were also multivariable predictors of recurrent AKI. Those who had higher acuity of illness during the initial hospitalization were more likely to have recurrent AKI, but greater AKI severity of the index episode was not independently associated with increased risk for recurrent AKI. In multivariable analysis of matched patients, recurrent AKI was associated with an increased rate of death (HR, 1.66; 95% CI, 1.57-1.77). LIMITATIONS: Analyses were based on clinically available data, rather than protocol-driven timed measurements of kidney function. CONCLUSIONS: Recurrent AKI is a common occurrence after a hospitalization complicated by AKI. Based on routinely available patient characteristics, our findings could facilitate identification of the subgroup of patients with AKI who may benefit from more intensive follow-up to potentially avoid recurrent AKI episodes.
Authors: Matthew T James; Brenda R Hemmelgarn; Natasha Wiebe; Neesh Pannu; Braden J Manns; Scott W Klarenbach; Marcello Tonelli Journal: Lancet Date: 2010-11-20 Impact factor: 79.321
Authors: Matthew T James; Morgan E Grams; Mark Woodward; C Raina Elley; Jamie A Green; David C Wheeler; Paul de Jong; Ron T Gansevoort; Andrew S Levey; David G Warnock; Mark J Sarnak Journal: Am J Kidney Dis Date: 2015-05-11 Impact factor: 8.860
Authors: Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245
Authors: Chi-yuan Hsu; Glenn M Chertow; Charles E McCulloch; Dongjie Fan; Juan D Ordoñez; Alan S Go Journal: Clin J Am Soc Nephrol Date: 2009-04-30 Impact factor: 8.237
Authors: Chi-Yuan Hsu; Kathleen D Liu; Jingrong Yang; David V Glidden; Thida C Tan; Leonid Pravoverov; Sijie Zheng; Alan S Go Journal: Clin J Am Soc Nephrol Date: 2019-12-16 Impact factor: 8.237
Authors: Henriette V Graversen; Simon K Jensen; Søren V Vestergaard; Uffe Heide-Jørgensen; Christian F Christiansen Journal: Kidney360 Date: 2021-11-15
Authors: David G Warnock; Javier A Neyra; Etienne Macedo; Ayme D Miles; Ravindra L Mehta; Christoph Wanner Journal: Nephron Date: 2021-08-20 Impact factor: 3.457
Authors: E Katsogridakis; T Lea; T Yap; A Batchelder; P Saha; A Diamantopoulos; N Saratzis; R Davies; H Zayed; M J Bown; A Saratzis Journal: Br J Surg Date: 2021-03-12 Impact factor: 6.939
Authors: Sandeep Brar; Kathleen D Liu; Alan S Go; Raymond K Hsu; Vernon M Chinchilli; Steven G Coca; Amit X Garg; Jonathan Himmelfarb; T Alp Ikizler; James Kaufman; Paul L Kimmel; Chirag R Parikh; Edward D Siew; Lorraine B Ware; Hui Zeng; Chi-Yuan Hsu Journal: Clin J Am Soc Nephrol Date: 2020-12-03 Impact factor: 8.237
Authors: Guozhi Jiang; Andrea O Luk; Claudia H T Tam; Risa Ozaki; Cadmon K P Lim; Elaine Y K Chow; Eric S Lau; Alice P S Kong; Baoqi Fan; Ka Fai Lee; Shing Chung Siu; Grace Hiu; Chiu Chi Tsang; Kam Piu Lau; Jenny Y Leung; Man-wo Tsang; Grace Kam; Ip Tim Lau; June K Li; Vincent T Yeung; Emmy Lau; Stanley Lo; Samuel Fung; Yuk Lun Cheng; Chun Chung Chow; Nelson L S Tang; Yu Huang; Hui-yao Lan; Richard A Oram; Cheuk Chun Szeto; Wing Yee So; Juliana C N Chan; Ronald C W Ma Journal: Diabetes Date: 2022-03-01 Impact factor: 9.461